Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 26, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001530893-26-000002
Filed / recorded
Feb 26, 2026, 11:11 PM UTC
Added to OQRO
Oct 2, 2026, 12:26 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ABBOTT LABORATORIES
Issuer CIK
1800
Ticker
ABT
Reporting person
Lisa D Earnhardt
Relationship
Officer
Officer title
EVP AND GROUP PRESIDENT
Security
Option (right to buy)
Table
Derivative (Table II)
Transaction date
Feb 24, 2026
Transaction code
A
Shares / units
111,533
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
111,533
Ownership form
Direct
Amendment
No
Footnotes from the filing
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,177 on February 24, 2027, 37,178 on February 24, 2028, and 37,178 on February 24, 2029.